Tactile Systems Technology, Inc. $TCMD Shares Purchased by Sei Investments Co.

Sei Investments Co. increased its stake in shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) by 101.5% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 65,511 shares of the company’s stock after acquiring an additional 32,995 shares during the period. Sei Investments Co. owned approximately 0.29% of Tactile Systems Technology worth $1,711,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of TCMD. Vanguard Group Inc. grew its stake in shares of Tactile Systems Technology by 4.8% during the fourth quarter. Vanguard Group Inc. now owns 1,651,170 shares of the company’s stock valued at $47,884,000 after acquiring an additional 76,198 shares in the last quarter. Paradigm Capital Management Inc. NY increased its position in shares of Tactile Systems Technology by 5.9% during the second quarter. Paradigm Capital Management Inc. NY now owns 1,618,600 shares of the company’s stock worth $16,413,000 after acquiring an additional 89,600 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Tactile Systems Technology by 2.1% in the third quarter. Dimensional Fund Advisors LP now owns 1,191,207 shares of the company’s stock worth $16,486,000 after acquiring an additional 24,001 shares in the last quarter. Federated Hermes Inc. boosted its holdings in Tactile Systems Technology by 19.4% in the fourth quarter. Federated Hermes Inc. now owns 645,408 shares of the company’s stock valued at $18,717,000 after purchasing an additional 104,648 shares during the last quarter. Finally, Deutsche Bank AG boosted its holdings in Tactile Systems Technology by 0.3% in the fourth quarter. Deutsche Bank AG now owns 578,669 shares of the company’s stock valued at $16,781,000 after purchasing an additional 1,482 shares during the last quarter. Hedge funds and other institutional investors own 83.43% of the company’s stock.

Tactile Systems Technology Price Performance

NASDAQ TCMD opened at $29.14 on Tuesday. Tactile Systems Technology, Inc. has a fifty-two week low of $12.01 and a fifty-two week high of $37.77. The stock’s 50-day moving average is $28.13 and its two-hundred day moving average is $27.06. The firm has a market cap of $657.40 million, a P/E ratio of 33.11 and a beta of 0.81.

Tactile Systems Technology (NASDAQ:TCMD) last released its earnings results on Monday, August 10th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.14 by $0.20. Tactile Systems Technology had a net margin of 5.91% and a return on equity of 9.70%. The firm had revenue of $85.70 million during the quarter, compared to analysts’ expectations of $85.52 million. On average, equities analysts expect that Tactile Systems Technology, Inc. will post 1.11 EPS for the current year.

Wall Street Analysts Forecast Growth

TCMD has been the subject of a number of research analyst reports. Weiss Ratings restated a “hold (c-)” rating on shares of Tactile Systems Technology in a research note on Monday, August 3rd. BTIG Research reaffirmed a “buy” rating and issued a $40.00 price target on shares of Tactile Systems Technology in a report on Thursday, May 21st. Finally, B. Riley Financial upgraded shares of Tactile Systems Technology from a “neutral” rating to a “buy” rating and increased their price objective for the company from $32.00 to $36.00 in a research note on Thursday, May 7th. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $38.60.

Tactile Systems Technology Company Profile

Tactile Systems Technology, Inc, headquartered in Plymouth, Minnesota, is a medical device company specializing in the design, manufacture and marketing of home-use pneumatic compression therapy systems for the treatment of lymphedema and other chronic edema-related conditions. Using proprietary software and patented pump technologies, the company’s platforms are designed to improve patient outcomes through sequential pressure treatment that promotes fluid mobilization and enhanced lymphatic function.

At the core of Tactile Systems’ product portfolio is the Flexitouch® system, a programmable pneumatic pump and garment system approved for home use, and the Aria® device, which features an intuitive touchscreen interface and advanced garment design.